Year: 2023
Type: article
Abstract: In vivo tissue-specific genome editing at the desired loci is still a challenge.Here, we report that AAV9-delivery of truncated guide RNAs (gRNAs) and Cas9 under the control of a computationally designed hepatocyte-specific promoter lead to liverspecific and sequence-specific targeting in the mouse factor IX (FIX) gene.The efficiency of in vivo targeting was assessed by T7E1 assays, site-specific Sanger sequencing and deep sequencing of on-target and putative off-target sites.Though AAV9 transduction was apparent in multiple tissues and organs, Cas9 expression was restricted mainly to the liver, with only minimal or no expression in other non-hepatic tissues.Consequently, the indel frequency was robust in the liver (up to 50%) in the desired target loci of the FIX gene, with no evidence of targeting in other organs or other putative off-target sites.This resulted in a substantial loss of FIX activity and the emergence of a bleeding phenotype, consistent with hemophilia B. The in vivo efficacy of the truncated gRNA was as high as that of full-length gRNA.Cas9 expression was transient in neonates, representing an attractive 'hit-and-run' paradigm.Our findings have potentially broad implications for somatic gene targeting in the liver using the CRISPR/Cas9 platform.
Author: Kshitiz Singh
Institution: Vrije Universiteit Brussel
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7001691976
